NCT06324240 2026-01-26
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
Emory University
Phase 1 Recruiting
Clinical Trials
10 trialsNCT03631043 2025-12-19
Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT05247996 2022-02-21
TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma
The Central Hospital of Lishui City
Phase NA Unknown
NCT03357276 2019-09-12
Mix Vaccine for Metastatic Colorectal Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT03357289 2019-09-12
Mix Vaccine for Metastatic Kidney Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT03357315 2019-09-12
Mix Vaccine for Metastatic Sarcoma Patients
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT01819558 2015-03-20
ALLO-WT1
Institut Paoli-Calmettes
Phase 1/2 Completed
NCT00324831 2013-12-18
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
Phase 3 Suspended
NCT00098917 2008-01-28
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00036426 2005-06-24
Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
Favrille
Phase 2 Unknown